These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3549247)

  • 21. Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats.
    Murray BM; Paller MS
    Clin Nephrol; 1986; 25 Suppl 1():S37-9. PubMed ID: 3708934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin A nephrotoxicity in streptozotocin-diabetic rats.
    Whiting PH; Thomson KJ; Saunders NJ; Simpson JG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):946-7. PubMed ID: 2705263
    [No Abstract]   [Full Text] [Related]  

  • 23. Mitochondrial alterations after cyclosporine and ischemia: insights on the pathophysiology of nephrotoxicity.
    Khauli RB; Strzelecki T; Kumar S; Fink M; Stoff J; Menon M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1395-7. PubMed ID: 3274339
    [No Abstract]   [Full Text] [Related]  

  • 24. Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration.
    Dieperink H; Kemp E; Leyssac PP; Starklint H; Wanscher M; Nielsen J; Jørgensen KA; Faber V; Flachs H
    Clin Nephrol; 1986; 25 Suppl 1():S137-43. PubMed ID: 3708923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex with reference to the rat and guinea pig.
    Duncan JI; Thomson AW; Aldridge RD; Simpson JG; Whiting PH
    Clin Nephrol; 1986; 25 Suppl 1():S14-7. PubMed ID: 3708924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine A in high dosages induces renal interstitial fibrosis in the rat.
    Dieperink H; Kemp E; Starklint H
    Transplant Proc; 1988 Jun; 20(3):525-7. PubMed ID: 3381259
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J; Taskinen E; Von Willebrand E
    Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity.
    Brown Z; Neild GH; Willoughby JJ; Somia NV; Cameron SJ
    Transplantation; 1986 Aug; 42(2):150-3. PubMed ID: 3090749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity.
    Jackson NM; Hsu CH; Visscher GE; Venkatachalam MA; Humes HD
    J Pharmacol Exp Ther; 1987 Aug; 242(2):749-56. PubMed ID: 3612560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphology of cyclosporine nephrotoxicity in the rat.
    Mihatsch MJ; Ryffel B; Hermle M; Brunner FP; Thiel G
    Clin Nephrol; 1986; 25 Suppl 1():S2-8. PubMed ID: 3708932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.
    Makowka L; Lopatin W; Gilas T; Falk J; Phillips MJ; Falk R
    Clin Nephrol; 1986; 25 Suppl 1():S89-94. PubMed ID: 3708941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in renal blood flow and kidney function by modulation of prostaglandin metabolism in cyclosporine-treated animals.
    Teraoka S; Takahashi K; Tanabe K; Yamaguchi Y; Kawai T; Tojinbara T; Nakajima I; Nakagawa Y; Fujikawa H; Hayashi T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):937-40. PubMed ID: 2784912
    [No Abstract]   [Full Text] [Related]  

  • 34. The role for reactive oxygen species in cyclosporin A induced nephrotoxicity in rats.
    Kumano K; Yoshida K; Iwamura M; Endo T; Sakai T; Nakamura K; Kuwao T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):941-2. PubMed ID: 2705262
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis of cyclosporine nephrotoxicity.
    Humes HD; Jackson N
    Dev Toxicol Environ Sci; 1986; 14():117-21. PubMed ID: 3829970
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine nephrotoxicity in rats with an acute reduction of renal function.
    Provoost AP
    Am J Kidney Dis; 1986 Nov; 8(5):314-8. PubMed ID: 3788970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995.
    Schuurman HJ; Beckmann N; Briner U; Bruns C; Bruttel K; Tanner M; Tolcsvai L; Weckbecker G
    Transplant Proc; 1996 Dec; 28(6):3272-5. PubMed ID: 8962271
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
    Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine nephrotoxicity: pathogenetic factors and prevention.
    Ryffel B; Mihatsch MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1635-6. PubMed ID: 3274392
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.